Literature DB >> 28450555

Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation.

Thorsten Derlin1, Faikah Gueler2, Jan Hinrich Bräsen3, Jessica Schmitz3, Dagmar Hartung4, Thomas R Herrmann5, Tobias L Ross6, Frank Wacker4, Hans-Jürgen Wester7, Marcus Hiss2, Hermann Haller2, Frank M Bengel6, Katja Hueper4.   

Abstract

Complicated urinary tract infections (UTIs) are frequent in immunosuppressed patients after kidney transplantation and may lead to allograft failure or urosepsis. Noninvasive detection of allograft involvement as well as localization of the primary site of infection are challenging. Therefore, we sought to determine whether molecularly targeted PET, combined with diffusion-weighted MRI, enables detection of leukocytes in renal allografts.
Methods: Thirteen kidney transplant recipients with complicated UTIs underwent both PET with a specific CXCR4 ligand, 68Ga-pentixafor, and diffusion-weighted MRI. The spatial distribution and intensity of CXCR4 upregulation in renal allografts as determined by SUVs on PET and diffusion restriction as determined by apparent diffusion coefficients (ADCs) on MRI were analyzed and compared with urinalysis, clinical chemistry and bacteriology, and biopsy, if available.
Results: Combined PET/MRI detected acute allograft infection in 9 patients and lower UTI/nonurologic infections in the remaining 4 patients. Leukocyte infiltration was identified by areas of CXCR4 upregulation compared with unaffected parenchyma in PET (SUVmean, 4.6 vs. 3.7; P < 0.01), corresponding to areas with increased cell density in MRI (ADCmin, 0.89 vs. 1.59 × 10-3 mm2/s, P < 0.01). Allograft CXCR4 signal was paralleled by CXCR4 upregulation in lymphoid organs. Histopathologic evaluation supported a correlation between CXCR4 signal and presence of leukocytes.
Conclusion: Combined CXCR4-targeted PET/MRI with 68Ga-pentixafor may enable the noninvasive detection of leukocytes in renal allografts. This novel methodology may refine the characterization of infectious and inflammatory kidney diseases and may serve as a platform for future clinical studies targeting allograft infection.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  CXCR4; magnetic resonance imaging (MRI); pentixafor; positron emission tomography (PET); urinary tract infection (UTI)

Mesh:

Substances:

Year:  2017        PMID: 28450555     DOI: 10.2967/jnumed.117.193037

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  11 in total

1.  68Ga-Pentixafor PET/CT for Imaging of Chemokine Receptor 4 Expression in Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.

Authors:  Yaping Luo; Xinxin Cao; Qingqing Pan; Jian Li; Jun Feng; Fang Li
Journal:  J Nucl Med       Date:  2019-05-17       Impact factor: 10.057

2.  Chemokine receptor-4 targeted PET/CT with 68Ga-Pentixafor in assessment of newly diagnosed multiple myeloma: comparison to 18F-FDG PET/CT.

Authors:  Qingqing Pan; Xinxin Cao; Yaping Luo; Jian Li; Jun Feng; Fang Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-27       Impact factor: 9.236

3.  A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.

Authors:  Theresa Osl; Alexander Schmidt; Markus Schwaiger; Margret Schottelius; Hans-Jürgen Wester
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

4.  Potential value of three-dimensional ultrasonography in diagnosis of diabetic nephropathy in Chinese diabetic population with kidney injury.

Authors:  Nan Li; Yi-Ru Wang; Xiao-Qi Tian; Lin Lin; Shu-Yuan Liang; Qiu-Yang Li; Xiang Fei; Jie Tang; Yu-Kun Luo
Journal:  BMC Nephrol       Date:  2020-06-29       Impact factor: 2.388

5.  Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury.

Authors:  Sahra Pajenda; Sazan Rasul; Marcus Hacker; Ludwig Wagner; Barbara Katharina Geist
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 6.  Recent advances in renal imaging.

Authors:  Joshua Thurman; Faikah Gueler
Journal:  F1000Res       Date:  2018-11-29

7.  Diffusion-weighted magnetic resonance imaging to assess diffuse renal pathology: a systematic review and statement paper.

Authors:  Anna Caroli; Moritz Schneider; Iris Friedli; Alexandra Ljimani; Sophie De Seigneux; Peter Boor; Latha Gullapudi; Isma Kazmi; Iosif A Mendichovszky; Mike Notohamiprodjo; Nicholas M Selby; Harriet C Thoeny; Nicolas Grenier; Jean-Paul Vallée
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

8.  Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarction.

Authors:  Rudolf A Werner; Annika Hess; Tobias Koenig; Johanna Diekmann; Thorsten Derlin; Anette Melk; James T Thackeray; Johann Bauersachs; Frank M Bengel
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

Review 9.  CXCR4-directed theranostics in oncology and inflammation.

Authors:  Malte Kircher; Peter Herhaus; Margret Schottelius; Andreas K Buck; Rudolf A Werner; Hans-Jürgen Wester; Ulrich Keller; Constantin Lapa
Journal:  Ann Nucl Med       Date:  2018-08-13       Impact factor: 2.668

10.  Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.

Authors:  Shanshan Tan; Hua Yang; Shenghui Xue; Jingjuan Qiao; Mani Salarian; Khan Hekmatyar; Yuguang Meng; Rao Mukkavilli; Fan Pu; Oluwatosin Y Odubade; Wayne Harris; Yan Hai; Melinda L Yushak; Vanessa M Morales-Tirado; Pardeep Mittal; Phillip Z Sun; David Lawson; Hans E Grossniklaus; Jenny J Yang
Journal:  Sci Adv       Date:  2020-02-07       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.